Trevena
TRVN
#10609
Rank
A$0.01 M
Marketcap
A$0.01807
Share price
0.00%
Change (1 day)
-99.31%
Change (1 year)

Revenue for Trevena (TRVN)

Revenue in 2024 (TTM): A$0.8 Million

According to Trevena's latest financial reports the company's current revenue (TTM ) is A$0.82 Million. In 2023 the company made a revenue of A$4.58 Million an increase over the revenue in the year 2022 that were of -A$0.62 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Trevena from 2013 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) A$0.8 M-82.42%
2023 A$4.58 M-846.73%
2022 -A$0.62 Million-178.54%
2021 A$0.78 M-80.4%
2020 A$3.99 M8914.34%
2019 A$0.04 M-99.46%
2018 A$8.13 M
2017 N/A-100%
2016 A$5.2 M-39.36%
2015 A$8.57 M
2014 N/A-100%
2013 A$0.15 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Amgen
AMGN
A$54.15 B 6,587,995.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
A$0.13 B 15,872.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Cara Therapeutics
CARA
A$10.74 M 1,207.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$96.70 B 11,764,552.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Arena Pharmaceuticals
ARNA
A$0.56 M-31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AcelRx Pharmaceuticals
ACRX
A$0.98 M 19.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Flexion Therapeutics
FLXN
A$0.15 B 18,288.28%๐Ÿ‡บ๐Ÿ‡ธ USA